164 related articles for article (PubMed ID: 19140232)
21. Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study.
Bini EJ; Mehandru S
Arch Intern Med; 2004 Nov; 164(21):2371-6. PubMed ID: 15557418
[TBL] [Abstract][Full Text] [Related]
22. Incidence of dysthyroidism during interferon therapy in chronic hepatitis C.
Benelhadj S; Marcellin P; Castelnau C; Colas-Linhart N; Benhamou JP; Erlinger S; Bok B
Horm Res; 1997; 48(5):209-14. PubMed ID: 9362390
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV-HIV co-infected patients before and after interferon alpha therapy: A prospective study.
Lowenstein A; Fainboim H; Reyes A; Lutzky C; Ameigeiras B; Schroder T; Eugenio Russmann ML
Endocrinol Diabetes Nutr (Engl Ed); 2020 Apr; 67(4):263-271. PubMed ID: 31266712
[TBL] [Abstract][Full Text] [Related]
24. The incidence and evolution of thyroid dysfunction during interferon-alpha therapy in children with chronic hepatitis B infection.
Kuloglu Z; Kansu A; Berberoglu M; Adiyaman P; Ocal G; Girgin N
J Pediatr Endocrinol Metab; 2007 Feb; 20(2):237-45. PubMed ID: 17396441
[TBL] [Abstract][Full Text] [Related]
25. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
[TBL] [Abstract][Full Text] [Related]
26. Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy.
Dalgard O; Bjøro K; Hellum K; Myrvang B; Bjøro T; Haug E; Bell H
J Intern Med; 2002 May; 251(5):400-6. PubMed ID: 11982739
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations.
Ward DL; Bing-You RG
Endocr Pract; 2001; 7(1):52-8. PubMed ID: 11250770
[TBL] [Abstract][Full Text] [Related]
28. Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?
Kozielewicz D; Zaleśna A; Dybowska D
Expert Opin Drug Saf; 2014 Aug; 13(8):1009-14. PubMed ID: 24930451
[TBL] [Abstract][Full Text] [Related]
29. Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy.
Andrade LJ; Atta AM; Atta ML; Mangabeira CN; Paraná R
Braz J Infect Dis; 2011; 15(4):377-81. PubMed ID: 21861010
[TBL] [Abstract][Full Text] [Related]
30. [Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha].
Földes I; Dávid K; Horváth G; Osztrogonácz H; Jankovics K; Tolvaj G
Orv Hetil; 2004 Jun; 145(23):1211-6. PubMed ID: 15264588
[TBL] [Abstract][Full Text] [Related]
31. Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis.
Kee KM; Lee CM; Wang JH; Tung HD; Changchien CS; Lu SN; Wang PW
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):319-26. PubMed ID: 16460494
[TBL] [Abstract][Full Text] [Related]
32. Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-alpha for chronic hepatitis C.
Kiehne K; Kloehn S; Hinrichsen H; Gallwitz B; Mönig H
Endocrine; 1997 Jun; 6(3):231-4. PubMed ID: 9368677
[TBL] [Abstract][Full Text] [Related]
33. [Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction].
Obołończyk L; Obołończyk L; Siekierska-Hellmann M; Sworczak K
Postepy Hig Med Dosw (Online); 2007 Jun; 62():309-21. PubMed ID: 18583950
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis.
Carella C; Amato G; Biondi B; Rotondi M; Morisco F; Tuccillo C; Chiuchiolo N; Signoriello G; Caporaso N; Lombardi G
Horm Res; 1995; 44(3):110-4. PubMed ID: 7590640
[TBL] [Abstract][Full Text] [Related]
35. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
[TBL] [Abstract][Full Text] [Related]
36. Interferon-alpha and autoimmune thyroid disease.
Prummel MF; Laurberg P
Thyroid; 2003 Jun; 13(6):547-51. PubMed ID: 12930598
[TBL] [Abstract][Full Text] [Related]
37. Effects of combined interferon alpha and ribavirin therapy on thyroid functions in patients with chronic hepatitis C.
Nadeem A; Aslam M; Khan DA; Hussain T; Khan SA
J Coll Physicians Surg Pak; 2009 Feb; 19(2):86-9. PubMed ID: 19208310
[TBL] [Abstract][Full Text] [Related]
38. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.
Deutsch M; Dourakis S; Manesis EK; Gioustozi A; Hess G; Horsch A; Hadziyannis S
Hepatology; 1997 Jul; 26(1):206-10. PubMed ID: 9214471
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of thyroid dysfunction in patients with chronić hepatitis C treated with pegylated interferon alpha and ribavirin.
Kozielewicz D; Wietlicka-Piszcz M; Halota W
Przegl Epidemiol; 2017; 71(4):555-569. PubMed ID: 29415534
[TBL] [Abstract][Full Text] [Related]
40. Low-titre auto-antibodies predict autoimmune disease during interferon-alpha treatment of chronic hepatitis C.
Bell TM; Bansal AS; Shorthouse C; Sandford N; Powell EE
J Gastroenterol Hepatol; 1999 May; 14(5):419-22. PubMed ID: 10355504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]